A novel ligand-modified nanocomposite microparticles improved efficiency of quercetin and paclitaxel delivery in the non-small cell lung cancer

References

• Agarwal R, Johnson CT, Imhoff BR, et al. (2018). Inhaled bacteriophage-loaded polymeric microparticles ameliorate acute lung infections. Nat Biomed Eng 2:841–9.
   PubMed Web of Science ®Google Scholar
• Araste F, Aliabadi A, Abnous K, et al. (2021). Self-assembled polymeric vesicles: Focus on polymersomes in cancer treatment. J Control Release 330:502–28.
   PubMed Web of Science ®Google Scholar
• Chvatal A, Farkas Á, Balásházy I, et al. (2017). Aerodynamic properties and in silico deposition of meloxicam potassium incorporated in a carrier-free Dpi pulmonary system. Int J Pharm 520:70–8.
   PubMedGoogle Scholar
• Goldman A, Majumder B, Dhawan A, et al. (2015). Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition. Nat Commun 6:13.
   Web of Science ®Google Scholar
• Hidalgo A, Garcia-mouton C, Autilio C, et al. (2021). Pulmonary surfactant and drug delivery: Vehiculization. J Control Release 329:205–22.
   PubMed Web of Science ®Google Scholar
• Hu J, Yuan X, Wang F, et al. (2021). The progress and perspective of strategies to improve tumor penetration of nanomedicines. Chin Chem Lett 32:1341–7.
   Web of Science ®Google Scholar
• Kwok PCL, Chan HK. (2013). Pulmonary drug delivery. Ther Deliv 4:877–8.
   PubMedGoogle Scholar
• Li S, Zhang Y, Ho SH, et al. (2020). Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles. Nat Biomed Eng 4:732–42.
   PubMed Web of Science ®Google Scholar
• Li Z, Wang F, Li Y, et al. (2021). Biomaterials combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting “substance p-hepatic stellate cells-hepatocellular carcinoma” axis. Biomaterials 276:121003.
   PubMed Web of Science ®Google Scholar
• Liang J, Wang J, Li S, et al. (2019). The size-controllable preparation of chitosan/silver nanoparticle composite microsphere and its antimicrobial performance. Carbohydr Polym 220:22–9.
   PubMed Web of Science ®Google Scholar
• Liang Y, Liu Z, Wang P, et al. (2021). Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant. J Control Release 336:396–409.
   PubMed Web of Science ®Google Scholar
• Liu K, Chen W, Yang T, et al. (2017). Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery. Int J Nanomedicine 12:8239–55.
   PubMed Web of Science ®Google Scholar
• Maya S, Kumar LG, Sarmento B, et al. (2013). Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells. Carbohydr Polym 93:661–9.
   PubMed Web of Science ®Google Scholar
• Okamoto Y, Taguchi K, Sakuragi M, et al. (2019). Preparation, characterization, and in vitro/in vivo evaluation of paclitaxel-bound albumin-encapsulated liposomes for the treatment of pancreatic cancer. ACS Omega 4:8693–700.
   PubMed Web of Science ®Google Scholar
• Roy A, Li SD. (2016). Modifying the tumor microenvironment using nanoparticle therapeutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol 8:891–908.
   PubMed Web of Science ®Google Scholar
• Ryu SH, Lee S, wookYang YJ, et al. (2012). Do intracytoplasmic epidermal growth factor receptor shows poor response to the cetuximab antitumor effect in irradiated non-small cell lung cancer cell lines. Lung Cancer 77:482–7.
   PubMed Web of Science ®Google Scholar
• Shahin M, Soudy R, Aliabadi HM, et al. (2013). Biomaterials engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity. Biomaterials 34:4089–97.
   PubMed Web of Science ®Google Scholar
• Sreeranganathan M, Uthaman S, Sarmento B, et al. (2017). Vivo evaluation of cetuximab-conjugated poly (γ -glutamic acid) -docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts. IJN 12:7165–82.
   Web of Science ®Google Scholar
• Stace CL, Ktistakis NT. (2006). Phosphatidic acid- and phosphatidylserine-binding proteins. Biochim Biophys Acta 1761:913–26.
   PubMed Web of Science ®Google Scholar
• Sun Q, Meenach SA, Torrico EA. (2019). Development and evaluation of paclitaxel-loaded aerosol nanocomposite microparticles and their efficacy against air-grown lung cancer tumor spheroids. ACS Biomater Sci Eng 5:6570–6580.
   PubMed Web of Science ®Google Scholar
• Tekade RK, Dutta T, Tyagi A, et al. (2008). Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy. J Drug Target 16:758–72.
   PubMed Web of Science ®Google Scholar
• Vermorken JB, Mesia R, Rivera F, et al. (2008). Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–27.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yu H, Wang S, et al. (2021). Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel. Mater Sci Eng C Mater Biol Appl 119:111442.
   PubMed Web of Science ®Google Scholar
• Wang Z, Cuddigan JL, Gupta SK, Meenach SA. (2016). Nanocomposite microparticles (NCmP) for the delivery of tacrolimus in the treatment of pulmonary arterial hypertension. Int J Pharm 512:305–13.
   PubMed Web of Science ®Google Scholar
• Wu H, Shi H, Zhang H, et al. (2014). Biomaterials prostate stem cell antigen antibody-conjugated multiwalled carbon nanotubes for targeted ultrasound imaging and drug delivery. Biomaterials 35:5369–80.
   PubMed Web of Science ®Google Scholar
• Yahya F, Sfouq F, El EF. Yahya Alqahtani. (2019). Paclitaxe. In: Profiles of Drug Substances, Excipients and Related Methodolog (Vol 44 p. 205–238). Elsevier.
   Google Scholar
• Yan Y, Dong Y, Yue S, Qiu, et al. (2019). Biological and medical applications of materials and interfaces dually active targeting nanomedicines based on a direct conjugate of two purely natural ligands for potent chemotherapy of ovarian tumor dually active targeting nanomedicines based on a direct of two purely ligands for potent chemotherapy of ovarian tumor. ACS Appl Mater Interfaces 11:46548–46557.
   Google Scholar
• Yang C, Zhang J, Liao M, et al. (2021). Folate-mediated one-carbon metabolism: A targeting strategy in cancer therapy. Drug Discov Today 26:817–25.
   PubMed Web of Science ®Google Scholar
• Yang Z, Tang W, Luo X, et al. (2015). Dual-ligand modified polymer-lipid hybrid nanoparticles for docetaxel targeting delivery to Her2/Neu. J Biomed Nanotechnol 11:1401–17.
   PubMed Web of Science ®Google Scholar
• Yoo J, Park C, Yi G, et al. (2019). Active targeting strategies using biological ligands for nanoparticle drug delivery systems. Cancers (Basel) 11:640.
   Google Scholar
• Yu J, Chen H, Jiang L, et al. (2019). Codelivery of adriamycin and P-Gp inhibitor quercetin using PEGylated liposomes to overcome cancer drug resistance. J Pharm Sci 108:1788–99.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Liu Q, Du M, et al. (2019). Cetuximab and doxorubicin loaded dextran-coated Fe3O4 magnetic nanoparti- cles as novel targeted nanocarriers for non-small cell lung cancer. J Magn Magn Mater 481:122–8.
   Web of Science ®Google Scholar
• Zhang X-Q, Lam R, Xu X, et al. (2011). Multimodal nanodiamond drug delivery carriers for selective targeting. Adv Mater 23:4770–5.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu P, Qin H, et al. (2021). Traditional Chinese medicine combined with pulmonary drug delivery system and idiopathic pulmonary fibrosis: rationale and therapeutic potential. Biomed Pharmacother 133:111072.
   PubMed Web of Science ®Google Scholar
• Zhen X, Wang X, Xie C, et al. (2013). Biomaterials cellular uptake, antitumor response and tumor penetration of cisplatin-loaded milk protein nanoparticles. Biomaterials 34:1372–82.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang J, Wang K, et al. (2020). Quercetin overcomes colon cancer cells resistance to chemotherapy by inhibiting solute carrier family, member transporter. Eur J Pharmacol 881:173185.
   PubMed Web of Science ®Google Scholar